Clinical Scorecard: Assessment of Depression Rates Among Advanced Cancer Patients Undergoing Palliative Care: A Meta-Analytical Review of Self-Reported Measures

At a Glance

Key Highlights

• Pooled prevalence of depression in this population is 50.9%
• Significant heterogeneity in prevalence estimates across studies
• Depression is commonly under-recognized in advanced cancer patients
• Standardized self-report scales are frequently used for assessment
• Need for valid screening and care strategies to alleviate emotional distress

Guideline-Based Recommendations

Diagnosis

• Use validated self-reported instruments to diagnose depression

Management

• Implement screening and intervention strategies for depression

Monitoring & Follow-up

• Regularly assess depression prevalence and patient well-being

Risks

• Increased pain, reduced treatment adherence, impaired communication, decreased overall well-being

Patient & Prescribing Data

Patients with advanced cancer aged 18 and older

Depression screening is essential in palliative care to improve quality of life

Clinical Best Practices

• Adopt suitable assessment tools for depression
• Conduct subgroup analyses to understand prevalence variations
• Ensure comprehensive care approaches that address emotional distress

Related Resources & Content

• Systematic review registration